- Home
- /
- Treatment
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Three-dimensional bioprinted therapeutic liver tissue | Organovo Inc. 6275 Nancy Ridge Drive San Diego, California, 92121 | January 9, 2018 | ||
Eflornithine + sulindac | 1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole | Cancer Prevention Pharmaceutical, Inc. 1760 East River Road, Suite 250 Tucson, Arizona, 85718 | January 9, 2018 | |
Abatacept | Ataxia Telangiectasia | Bristol-Myers Squibb Co. P.O Box 4000 Princeton, New Jersey, 08543 | January 9, 2018 | |
2-O, 3-O, desulfated heparin | Pseudo-Zellweger syndrome | Cantex Pharmaceuticals, Inc. 1792 Bell Tower Lane Weston, Florida, 33326 | January 9, 2018 | |
Mosedipimod | Complex 5 mitochondrial respiratory chain deficiency | Enzychem Lifesciences Corporation 59, Bio valley-ro Jecheon-si | January 9, 2018 | |
Fenretinide | 1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole | SciTech Development, LLC 281 Kercheval Avenue Grosse Pointe Farms, Michigan, 48236 | January 9, 2018 | |
DaxibotulinumtoxinA | 1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole | Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark, California, 94560 | January 9, 2018 | |
Lentiviral transfected chimeric antigen receptor T-cells modified to target B-cell maturation antigen and CS1 | 1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole | iCell Gene Therapeutics 25 Health Sciences Drive, Suite 118 Stony Brook, New York, 11793 | January 9, 2018 | |
Cholera toxin B subunit | 1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole | Aliment Wellness LLC 9462 Brownsboro Road, Suite 340 Louisville, Kentucky, 40241 | January 9, 2018 | |
Eflornithine + sulindac | Pancreatic Cancer | Cancer Prevention Pharmaceutical, Inc.;1760 East River Road, Suite 250;Tucson, Arizona, 85718 | January 8, 2018 | |
Cryopreserved human umbilical cord | Spina bifida | TissueTech, Inc.;7300 Corporate Center Drive, Suite 700;Miami, Florida, 33126 | January 8, 2018 | |
Genetically modified, non-self replicating Adeno-Associated Virus serotype 9 expressing shRNA to knock down mutant PABP1 as well as a codon optimized, shRNA-insensitive, wildtype PABN1 | Oculopharyngeal muscular dystrophy | Benitec Biopharma;99 Mount Street, Suite 1201;North Sydney | January 8, 2018 | |
Milrinone | Right heart failure (RHF) in left ventricular assist device (LVAD) patients | Cardiora Pty Ltd;Level 9, 278 Collins Street;Melbourne | January 8, 2018 | |
Atezolizumab + Bevacizumab | Hepatocellular Carcinoma | Genentech, Inc.;1 DNA Way, Mail Stop # 355e;South San Francisco, California, 94080 | January 8, 2018 | |
Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC) | Glioblastoma | AXIUM Pharmaceuticals, Inc.;265 Eastchester Drive, Suite 133, #201;High Point, North Carolina, 27262 | January 8, 2018 | |
Antibody drug conjugate targeting dipeptidase 3 (DPEP3) | DPEP3-positive ovarian, fallopian tube, and primary peritoneal cancers | AbbVie Stemcentrx, LLC;1 North Waukegan Road;Chicago, Illinois, 60064 | January 8, 2018 | |
ICG140:CD19-CD123 cCAR T-cells, a chimeric antigen receptor (CAR) on the surface of T-cells directed against the target proteins CD19 and CD 123 | iCell Gene Therapeutics 25 Health Sciences Drive, Suite 118 Stony Brook, New York, 11793 | January 4, 2018 | ||
Resatorvid | Acute-on-chronic liver failure | Takeda Development Center Americas, Inc.;One Takeda Parkway;Deerfield, Illinois, 60015 | January 2, 2018 | |
Partial myostatin antigen displayed on the surface of Lactobacillus casei | Duchenne muscular dystrophy | BioLeaders Corporation;7F, U-Tower, 767, Sinsu-ro, Suji-gu;Yongin-si | December 28, 2017 | |
ICG140:CD19-CD123 cCAR T-cells, a chimeric antigen receptor (CAR) on the surface of T-cells directed against the target proteins CD19 and CD 123 | Acute lymphoblastic leukemia | iCell Gene Therapeutics;25 Health Sciences Drive, Suite 118;Stony Brook, New York, 11793 | December 26, 2017 | |
Abatacept | Graft Versus Host Disease | Bristol-Myers Squibb Co.;P.O Box 4000;Princeton, New Jersey, 08543 | December 26, 2017 | |
(+)-(2S)-2-(4-chloro-2-methoxyphenyl)-2-{[3-methoxy-5-(methylsulfonyl)phenyl]amino}-1-[5-(trifluoromethoxy)-1H-indol-3-yl]ethanone | Dengue virus infection | Janssen Research & Development, LLC;125 Trenton-Harbourton Road;Titusville, New Jersey, 08560 | December 26, 2017 | |
3-[2-(1-methylpyrrolidin-2-yl) ethyl]-6-(2-pyrrolidin-1yl) ethyl-9-benzyloxycarbonyl-12-diethyl-4,7-dioxo-3,6,9,12-tetraazadodecancarboxamide | Anterior ischemic optic neuropathy | Neurizon Pharma;15 Paul-Ehrlich-Stra�e;T�bingen | December 26, 2017 | |
Fenretinide | Follicular lymphoma | SciTech Development, LLC;281 Kercheval Avenue;Grosse Pointe Farms, Michigan, 48236 | December 22, 2017 | |
Soraprazan | Stargardt Disease | Katairo GmbH;21 Lederstra�e;Kusterdingen | December 22, 2017 |